Cannabis use disorder (CUD) is associated with increased risk of benign salivary gland tumors, according to a research letter published online July 17 in JAMA Otolaryngology-Head & Neck Surgery.

Curaleaf posted record Q1 margins and strong international growth despite falling revenue and a steep stock decline. Find out why CURLF stock is a hold.